Global Virtual Clinical Trials Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

Description

List of Tables

The global demand for Virtual Clinical Trials Market is presumed to reach the market size of nearly USD 26.12 BN by 2030 from USD 12.24 BN in 2022 with a CAGR of 9.94% under the study period 2023 - 2030.

A virtual clinical trial refers to clinical trial techniques facilitated by technology. A virtual approach enables individuals to participate in the trial from the convenience of their homes, ensuring that research may continue even when site visits are inconvenient. As a result, it provides an innovative tool for gathering safety and efficacy information from clinical study participants. These solutions consider the countless advantages of technology, advanced software, gadgets, online social networking sites, robotic process automation, machine learning, and others. These virtual clinical trials are convenient, affordable, and patient-focused.

Market Dynamics:

The virtual clinical trial approach is more comfortable, patient-centered, and cost-effective, so virtual trials are becoming more popular and are growing. The government's attempt to increase public awareness also assists in the market expansion of virtual clinical trials. As the demand for a practical, time-saving, easy, safe platform for clinical purposes grows, so does the market for these trials is expected to scale up. Moreover, the market is growing since a lot of manufacturers are funding R&D initiatives. However,lack of public awareness may hamper the expansion of the virtual clinical trial market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of virtual clinical trials. The growth and trends of virtual clinical trials industry provide a holistic approach to this study.

Market Segmentation:

This section of the virtual clinical trials market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Study Design

Interventional
Observational
Expanded Access

By Indication

CNS
Autoimmune/Inflammation
Cardiovascular Disease
Metabolic/Endocrinology
Infectious Disease
Oncology
Genitourinary
Ophthalmology
Others

By Phase

Phase I
Phase II
Phase III
Phase Iv

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Virtual Clinical Trials market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the virtual clinical trials market include ICON PLC, Parexel International Corporation, IQVIA, Covance, PRA Health Sciences, LEO Innovation Lab, Medidata, Oracle, CRF Health, Clinical Ink, Medable Inc, Clinical Ink, Halo Health Systems, Croprime. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

Product Code: VMR11219982

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . VIRTUAL CLINICAL TRIALS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Study Design
- 3.7.2 Market Attractiveness Analysis By Indication
- 3.7.3 Market Attractiveness Analysis By Phase
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL VIRTUAL CLINICAL TRIALS MARKET ANALYSIS BY STUDY DESIGN

6.1 Overview by Study Design
6.2 Historical and Forecast Data
6.3 Analysis by Study Design
6.4 Interventional Historic and Forecast Sales by Regions
6.5 Observational Historic and Forecast Sales by Regions
6.6 Expanded Access Historic and Forecast Sales by Regions

7 . GLOBAL VIRTUAL CLINICAL TRIALS MARKET ANALYSIS BY INDICATION

7.1 Overview by Indication
7.2 Historical and Forecast Data
7.3 Analysis by Indication
7.4 CNS Historic and Forecast Sales by Regions
7.5 Autoimmune/Inflammation Historic and Forecast Sales by Regions
7.6 Cardiovascular Disease Historic and Forecast Sales by Regions
7.7 Metabolic/Endocrinology Historic and Forecast Sales by Regions
7.8 Infectious Disease Historic and Forecast Sales by Regions
7.9 Oncology Historic and Forecast Sales by Regions
7.10. Genitourinary Historic and Forecast Sales by Regions
7.11 Ophthalmology Historic and Forecast Sales by Regions
7.12 Others Historic and Forecast Sales by Regions

8 . GLOBAL VIRTUAL CLINICAL TRIALS MARKET SALES ANALYSIS BY PHASE

8.1 Overview by Phase
8.2 Historical and Forecast Data
8.3 Analysis by Phase
8.4 Phase I Historic and Forecast Sales by Regions
8.5 Phase II Historic and Forecast Sales by Regions
8.6 Phase III Historic and Forecast Sales by Regions
8.7 Phase IV Historic and Forecast Sales by Regions

9 . GLOBAL VIRTUAL CLINICAL TRIALS MARKET SALES ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook Sales Analysis
9.2. Introduction Sales Analysis
9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE VIRTUAL CLINICAL TRIALS COMPANIES

10.1. Virtual Clinical Trials Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF VIRTUAL CLINICAL TRIALS INDUSTRY

11.1. Top 10 Company Share Analysis
11.2. Market Concentration Rate
11.3. ICON PLC
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Parexel International Corporation
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. IQVIA
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. Covance
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. PRA Health Sciences
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. LEO Innovation Lab
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. Medidata
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments
11.10. Oracle
- 11.10.1. Company Overview
- 11.10.2. Company Revenue
- 11.10.3. Products
- 11.10.4. Recent Developments
11.11. CRF Health
- 11.11.1. Company Overview
- 11.11.2. Company Revenue
- 11.11.3. Products
- 11.11.4. Recent Developments
11.12. Clinical Ink
- 11.12.1. Company Overview
- 11.12.2. Company Revenue
- 11.12.3. Products
- 11.12.4. Recent Developments
11.13. Medable Inc
- 11.13.1. Company Overview
- 11.13.2. Company Revenue
- 11.13.3. Products
- 11.13.4. Recent Developments
11.14. Clinical Ink
- 11.14.1. Company Overview
- 11.14.2. Company Revenue
- 11.14.3. Products
- 11.14.4. Recent Developments
11.15. Halo Health Systems
- 11.15.1. Company Overview
- 11.15.2. Company Revenue
- 11.15.3. Products
- 11.15.4. Recent Developments
11.16. Croprime
- 11.16.1. Company Overview
- 11.16.2. Company Revenue
- 11.16.3. Products
- 11.16.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies